theraputic effects of celery, dill and green tea combination in treatment of metabolic syndrome in patients with schizophrenia

Comparing theraputic effects of celery, dill and green tea combination with placebo in treatment of metabolic syndrome in patients with schizophrenia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013102915206N1

Enrollment

Registered

2014-02-24

Start date

2013-06-26

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia. Schizophrenia

Interventions

Intervention 1: Intervention group: prescription of tablet composed of extracts of celery, dill, and green tea three times a day half an hour before meal for 3 consecutive months. Intervention 2: Cont

Treatment - Drugs

Placebo

Intervention group: prescription of tablet composed of extracts of celery, dill, and green tea three times a day half an hour before meal for 3 consecutive months.

Control group: prescription of a tablet with identical appearance to the herbal combination tablet three times a day half an hour before meal for 3 consecutive months.

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: diagnosis of schizophrenia and metabolic syndrome; age between 18 and 65 years; female; agreement of patient and her guardian towards participation in the trial. Exclusion criteria: any change in the schizophrenia medication within two months prior to the trial; coexistence of another major mental disorder; any hyper sensitive reaction to the medication; exacerbation of mental symptoms.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Weist circumference. Timepoint: 3 months. Method of measurement: By a regular meter,cm.;Blood pressure. Timepoint: 3 months. Method of measurement: Pressure guage,mmHg.;Fasting blood sugar. Timepoint: 3 months. Method of measurement: md/ml, evaluation of venous blood sample by spectrophotometer.;HDL(high density lipoprotein). Timepoint: 3 months. Method of measurement: mg/ml, evaluation of venous blood sample by spectrophotometer.;TG(triglycerides). Timepoint: 3 months. Method of measurement: mg/ml, evaluation of venous blood sample by spectrophotometer.	—

Measure

Time frame

Weist circumference. Timepoint: 3 months. Method of measurement: By a regular meter,cm.;Blood pressure. Timepoint: 3 months. Method of measurement: Pressure guage,mmHg.;Fasting blood sugar. Timepoint: 3 months. Method of measurement: md/ml, evaluation of venous blood sample by spectrophotometer.;HDL(high density lipoprotein). Timepoint: 3 months. Method of measurement: mg/ml, evaluation of venous blood sample by spectrophotometer.;TG(triglycerides). Timepoint: 3 months. Method of measurement: mg/ml, evaluation of venous blood sample by spectrophotometer.

—

Secondary

Measure	Time frame
Gastrointestinal dyscomfort. Timepoint: 3 months after intervention. Method of measurement: Personal interview.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEmytis Tavakoli

University of social welfare and rehabilitation sciences

tavakoli79@yahoo.com; em.tavakoli@uswr.ac.ir+98 21 3340 1604

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026